Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-03-27 | Geno Germano has served as President and Chief Executive Officer and as a board member of Elucida Oncology, Inc. ... Mr. Germano received his Bachelor of Science in Pharmacy from Albany College of Pharmacy. |
| 2021-04-12 | Mr. Germano has experience leading pharmaceutical businesses and strategic roles, with a Bachelor of Science in Pharmacy. |
| 2022-03-29 | Mr. Germano has served as President and CEO of Elucida Oncology, Inc., and previously as President of Intrexon Corporation, a leader in engineering and industrialization of biology, but no software programming background is indicated. |
| 2023-03-23 | Geno Germano has served as a member of our Board of Directors since March 2020. Since August 2018, Mr. Germano has served as President and Chief Executive Officer and a board member of Elucida Oncology, Inc., a biotechnology company... Mr. Germano received his Bachelor of Science in Pharmacy from Albany College of Pharmacy. |
| 2023-12-04 | Geno Germano(9) Consists of 261,527 shares of common stock underlying options exercisable within 60 days of November 15, 2023. |
| 2024-04-25 | Mr. Germano has served as President and CEO of Elucida Oncology, Inc. and was Group President of the Global Innovative Pharma Business of Pfizer Inc. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-25